Related Experiment Video

Updated: Jun 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome

Blanca Fuentes1, Patricia Martínez-Sánchez, Exuperio Díez-Tejedor

  • 1Stroke Unit, Department of Neurology, La Paz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.

Cerebrovascular Diseases (Basel, Switzerland)
|April 4, 2009
PubMed

Insights

Dyslipidemia is a modifiable stroke risk factor. Long-term statin therapy, particularly atorvastatin 80 mg, reduces stroke recurrence and improves outcomes in acute stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Dyslipidemia is a known risk factor for coronary artery disease.
  • The association between dyslipidemia and stroke risk has been debated.
  • Lipid-lowering therapies are increasingly recognized for stroke risk reduction.

Purpose of the Study:

  • To review the association between serum lipids and stroke risk.
  • To evaluate the efficacy of lipid-modifying therapies in stroke prevention and management.
  • To assess the impact of prior statin use on acute stroke severity.

Main Methods:

  • Nonsystematic review of published studies.
  • Analysis of cohort studies, case-control studies, and clinical trials.
  • Focus on lipid-lowering drugs (statins, HDL-increasing agents) and statin pretreatment effects.

Main Results:

  • Serum lipids are confirmed to be associated with stroke risk.
  • Atorvastatin 80 mg is effective for secondary stroke prevention in specific patient groups.
  • Pretreatment with statins improves outcomes in acute stroke patients, especially for atherothrombotic and lacunar infarcts.
  • Statin withdrawal is linked to a loss of protective effect and increased mortality.

Conclusions:

  • Dyslipidemia is a treatable risk factor for stroke.
  • Sustained atorvastatin 80 mg therapy reduces stroke recurrence and cardiovascular events.
  • Prior statin use is associated with reduced stroke severity and better patient outcomes.
  • Discontinuation of statin therapy in indicated patients should be avoided.
Abstract

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...